Beijing Bohui Innovation Biotechnology Group Co., Ltd. Stock
Equities
300318
CNE000001QR4
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.21 CNY | +0.77% | +13.02% | -16.51% |
Sales 2022 | 796M 110M | Sales 2023 | 1.05B 144M | Capitalization | 5.1B 704M |
---|---|---|---|---|---|
Net income 2022 | -78M -10.77M | Net income 2023 | -24M -3.32M | EV / Sales 2022 | 6.85 x |
Net Debt 2022 | 674M 93.15M | Net Debt 2023 | 703M 97.15M | EV / Sales 2023 | 5.55 x |
P/E ratio 2022 |
-61
x | P/E ratio 2023 |
-205
x | Employees | 1,773 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.67% |
1 day | +0.77% | ||
1 week | +13.02% | ||
Current month | -3.16% | ||
1 month | -3.16% | ||
3 months | -3.16% | ||
6 months | -14.03% | ||
Current year | -16.51% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Jiang
CEO | Chief Executive Officer | 54 | 20-03-16 |
Hai Feng Dong
DFI | Director of Finance/CFO | 40 | 20-06-28 |
Jiang Hong Du
CHM | Chairman | 56 | 01-06-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jiang Hong Du
CHM | Chairman | 56 | 01-06-25 |
Jun Ban
BRD | Director/Board Member | 57 | 20-06-28 |
Zhi Wei Shen
CHM | Chairman | 46 | 22-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.99% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 5.21 | +0.77% | 10,841,940 |
24-04-29 | 5.17 | +8.16% | 21,281,940 |
24-04-26 | 4.78 | -.--% | 7,431,750 |
24-04-25 | 4.78 | +2.36% | 8,360,084 |
24-04-24 | 4.67 | +0.86% | 5,519,484 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.51% | 588M | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-17.32% | 31.47B | |
+54.44% | 25.24B | |
-12.64% | 15.82B | |
-9.12% | 11.96B | |
-15.43% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- 300318 Stock